Philémon Sirven

4.0k total citations · 3 hit papers
21 papers, 2.5k citations indexed

About

Philémon Sirven is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Philémon Sirven has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Philémon Sirven's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (5 papers). Philémon Sirven is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (5 papers). Philémon Sirven collaborates with scholars based in France, Italy and United States. Philémon Sirven's co-authors include Anne Vincent‐Salomon, Vassili Soumelis, Fatima Mechta‐Grigoriou, Yann Kieffer, Alix Scholer‐Dahirel, Ilaria Magagna, Mélissa Cardon, Ana Costa, Claire Bonneau and Floriane Pelon and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Philémon Sirven

19 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

2018 1.2k citations Ana Costa, Yann Kieffer et al. Cancer Cell profile →
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

2022 173 citations Eleonora Timperi, Paul Gueguen et al. Cancer Research profile →
Selective STING stimulation in dendritic cells primes antitumor T cell responses

2023 103 citations Aurore Bochnakian, Caroline Hoffmann et al. Science Immunology profile →

Peers

Countries citing papers authored by Philémon Sirven

Since Specialization

Citations

This map shows the geographic impact of Philémon Sirven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philémon Sirven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philémon Sirven more than expected).

Fields of papers citing papers by Philémon Sirven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philémon Sirven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philémon Sirven. The network helps show where Philémon Sirven may publish in the future.

Co-authorship network of co-authors of Philémon Sirven

This figure shows the co-authorship network connecting the top 25 collaborators of Philémon Sirven. A scholar is included among the top collaborators of Philémon Sirven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philémon Sirven. Philémon Sirven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanistic insight for T-cell exclusion by cancer-associated fibroblasts in human lung cancer 2025 ·eLife ·(unknown), C Bernard, Philémon Sirven, Hélène Salmon, Massimiliano Fraldi, Martine Ben Amar	0
2	Mechanistic insight for T-cell exclusion by cancer-associated fibroblasts in human lung cancer 2024 ·eLife ·(unknown), C Bernard, Philémon Sirven, Hélène Salmon, Massimiliano Fraldi, Martine Ben Amar	0
3	Selective STING stimulation in dendritic cells primes antitumor T cell responses breakdown → 2023 ·Science Immunology ·(unknown), Aurore Bochnakian, Caroline Hoffmann, (unknown), (unknown), Philémon Sirven, Jordan Denizeau, Christine Sedlik, Yohan Gerber-Ferder, Frédéric Di Fiore, (unknown), (unknown), Robert A. Kramer, Ian Walters, (unknown), Hélène Salmon, Bernard Malissen, Marc Dalod, Eliane Piaggio, Nicolas Manel	103
4	Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer breakdown → 2022 ·Cancer Research ·Eleonora Timperi, Paul Gueguen, Martina Molgora, Ilaria Magagna, Yann Kieffer, (unknown), Philémon Sirven, Laura G. Baudrin, Sylvain Baulande, Nicolás André, Gabriel Champenois, Didier Meseure, Anne Vincent‐Salomon, A. Tardivon, Enora Laas, Vassili Soumelis, Marco Colonna, Fatima Mechta‐Grigoriou, Sebastián Amigorena, Emanuela Romano	173
5	Definition of a novel breast tumor-specific classifier based on secretome analysis 2022 ·Breast Cancer Research ·Philémon Sirven, (unknown), Maximilien Grandclaudon, Paula Michea, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou, Alix Scholer‐Dahirel, Maude Guillot‐Delost, Vassili Soumelis	3
6	PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity 2022 ·Nature Communications ·Caroline Hoffmann, Floriane Noël, Maximilien Grandclaudon, Lucile Massenet-Regad, Paula Michea, Philémon Sirven, (unknown), (unknown), Olivier Lantz, Mylène Bohec, Jian Ye, Weihua Guo, Juliette Rochefort, Jerzy Klijanienko, Sylvain Baulande, Charlotte Lecerf, Maud Kamal, Christophe Le Tourneau, Maude Guillot‐Delost, Vassili Soumelis	23
7	Extracellular vesicles from triple negative breast cancer promote pro-inflammatory macrophages associated with better clinical outcome 2022 ·Proceedings of the National Academy of Sciences ·Mercedes Tkach, Jessie Thalmensi, Eleonora Timperi, Paul Gueguen, Nathalie Névo, Eleonora Grisard, Philémon Sirven, Federico Cocozza, (unknown), Lorena Martín‐Jaular, Mabel Jouve, (unknown), Nicolas Manel, Derek C. Rookhuizen, Coralie L. Guérin, Vassili Soumelis, Emanuela Romano, Élodie Segura, Clotilde Théry	83
8	A Quantitative Multivariate Model of Human Dendritic Cell-T Helper Cell Communication 2019 ·Cell ·Maximilien Grandclaudon, (unknown), Coline Trichot, Léa Karpf, (unknown), Camille Chauvin, Philémon Sirven, Wassim Abou-Jaoudé, Frédérique Berger, Philippe Hupé, Denis Thieffry, (unknown), Julien Chiquet, Céline Lévy‐Leduc, Vassili Soumelis	21
9	A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer 2019 ·OncoImmunology ·(unknown), Maximilien Grandclaudon, (unknown), Philémon Sirven, Frédérique Berger, Anne‐Sophie Hamy, Virginie Fourchotte, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou, Fabien Reyal, Alix Scholer‐Dahirel, Maude Guillot‐Delost, Vassili Soumelis	27
10	Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific 2018 ·Nature Immunology ·Paula Michea, Floriane Noël, Ève Zakine, Urszula Czerwińska, Philémon Sirven, (unknown), Christel Goudot, Alix Scholer‐Dahirel, Anne Vincent‐Salomon, Fabien Reyal, Sebastián Amigorena, Maude Guillot‐Delost, Élodie Segura, Vassili Soumelis	162
11	Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer breakdown → 2018 ·Cancer Cell ·Ana Costa, Yann Kieffer, Alix Scholer‐Dahirel, Floriane Pelon, Brigitte Bourachot, Mélissa Cardon, Philémon Sirven, Ilaria Magagna, Laetitia Fuhrmann, Charles Bernard, Claire Bonneau, Maria Kondratova, Inna Kuperstein, Andreï Zinovyev, (unknown), Maria‐Carla Parrini, Vassili Soumelis, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou	1170
12	miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers 2018 ·Nature Communications ·(unknown), Yann Kieffer, Alix Scholer‐Dahirel, Philémon Sirven, Mélissa Cardon, Floriane Pelon, Ilaria Magagna, Géraldine Gentric, Ana Costa, Claire Bonneau, Virginie Mieulet, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou	208
13	Diversification of human plasmacytoid predendritic cells in response to a single stimulus 2017 ·Nature Immunology ·(unknown), Violaine Saint‐André, Jérémy Di Domizio, Pablo Vargas, Philémon Sirven, Pierre Bost, (unknown), Paolo Maiuri, Maxime Wéry, Mabel San Roman, Léa Savey, Maxime Touzot, Benjamin Terrier, David Saadoun, Curdin Conrad, Michel Gilliet, Antonin Morillon, Vassili Soumelis	108
14	Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane 2017 ·Nature Communications ·Alexandros Glentis, Philipp Oertle, Pascale Mariani, Aleksandra Chikina, Fatima El Marjou, Youmna Attieh, François Zaccarini, Marick Laé, Damarys Loew, Florent Dingli, Philémon Sirven, Marie Schoumacher, (unknown), Marija Plodinec, Danijela Matic Vignjevic	266
15	CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients 2016 ·Oncogene ·Sylvain Lefort, Aurélie Thuleau, Yann Kieffer, Philémon Sirven, Ivan Bièche, Elisabetta Marangoni, Anne Vincent‐Salomon, Fatima Mechta‐Grigoriou	68
16	No evidence for TSLP pathway activity in human breast cancer 2016 ·OncoImmunology ·Cristina Ghirelli, Benjamin Sadacca, Fabien Reyal, Raphaël Zollinger, Paula Michea, Philémon Sirven, Lucia Pattarini, (unknown), Maude Guillot‐Delost, Nicolás André, Alix Scholer‐Dahirel, Vassili Soumelis	24
17	Breast Cancer Cell–Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes 2015 ·Cancer Research ·Cristina Ghirelli, Fabien Reyal, Marine Jeanmougin, Raphaël Zollinger, Philémon Sirven, Paula Michea, Christophe Caux, Nathalie Bendriss‐Vermare, Marie‐Hélène Donnadieu, Martial Caly, Virginie Fourchotte, Anne Vincent‐Salomon, Brigitte Sigal‐Zafrani, Xavier Sastre‐Garau, Vassili Soumelis	46
18	In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R 2009 ·Molecular Immunology ·Philémon Sirven, Florence Castelli, (unknown), Natacha Szely, Bernard Maillère	11
19	Characterization of HLA Class II/Peptide-TCR Interactions of the Immunodominant T Cell Epitope in Art v 1, the Major Mugwort Pollen Allergen 2008 ·The Journal of Immunology ·Beatrice Jahn‐Schmid, Philémon Sirven, Victoria Leb, Winfried F. Pickl, Gottfried Fischer, Gabriele Gadermaier, Matthias Egger, Christof Ebner, Fátima Ferreira, Bernard Maillère, Barbara Bohle	19
20	The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes 2007 ·Clinical & Experimental Allergy ·(unknown), Tuure Kinnunen, Philémon Sirven, Antti Taivainen, Diane Houitte, Juha Peräsaari, Ale Närvänen, Soili Saarelainen, Marja Rytkönen‐Nissinen, Bernard Maillère, Tuomas Virtanen	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact